Formulators of parenteral drugs must be cautious of specific considerations and challenges that arise during development and manufacture. As the numbers of poorly soluble and complex molecules, such ...

According to Theratechnologies, Egrifta WR is set to replace Egrifta SV. The Food and Drug Administration (FDA) has approved Egrifta WR ™, a new concentrated formulation (F8) of tesamorelin, for the ...

Insights into molecular behaviors and predictive capabilities are bringing numerous benefits. The potential benefits afforded by molecular modeling when applied to formulation development are, in fact ...

The new formulation significantly reduced injection site pain compared with the original. A new citrate-free formulation of Taltz ® (ixekizumab) has been made available by Eli Lilly. Taltz, an ...

Intrepid Labs’ Valiant platform uses AI and robotics to cut drug formulation timelines from months to days Over $11M USD total raised to-date; latest round led by AVANT BIO TORONTO--(BUSINESS ...

Formulation 4.1 continues the story of bringing digital to all aspect of formulation and looks at how Industry 4.0 is changing the formulation industry. The meeting will showcase ongoing activities ...

To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...

Benzoyl peroxide is a cornerstone treatment for acne, without a clear alternative. However, concerns have been raised about the potential formation of benzene, a known carcinogen, in some benzoyl ...